发明授权
US4530838A Synthetic calcitonin-gene-related peptides for lowering blood pressure
or gastric acid secretion in mammals
失效
用于降低哺乳动物血压或胃酸分泌的合成降钙素基因相关肽
- 专利标题: Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
- 专利标题(中): 用于降低哺乳动物血压或胃酸分泌的合成降钙素基因相关肽
-
申请号: US512421申请日: 1983-07-08
-
公开(公告)号: US4530838A公开(公告)日: 1985-07-23
- 发明人: Ronald M. Evans , Larry Swanson , Wylie W. Vale, Jr. , Michael G. Rosenfeld , Susan G. Amara , Marvin R. Brown , Jean E. F. Rivier
- 申请人: Ronald M. Evans , Larry Swanson , Wylie W. Vale, Jr. , Michael G. Rosenfeld , Susan G. Amara , Marvin R. Brown , Jean E. F. Rivier
- 申请人地址: CA San Diego
- 专利权人: The Salk Institute for Biological Studies
- 当前专利权人: The Salk Institute for Biological Studies
- 当前专利权人地址: CA San Diego
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; C07K14/575 ; A61K37/02 ; C07C103/52
摘要:
CGRP (calcitonin-gene-related peptide) has the formula: ##STR1## A related peptide has the residue Lys instead of Glu in the 35-position. CGRP or this homolog or pharmaceutically acceptable salts thereof, dispersed in a pharmaceutically acceptable liquid or solid carrier, can be administered to mammals, including humans, to influence memory, mood and pain appreciation and to achieve a substantial lowering of blood pressure or gastric acid secretion over an extended period of time. They also may be administered to affect ingestion behavior, taste and sensory perception.
信息查询
IPC分类: